Prenetics Global Ltd. (PRE) intrinsic value & 10-year financials
Prenetics Global Ltd. (PRE) has a Graham intrinsic value of $82.96 per share. Over the last 6 fiscal years revenue shrank 17.2% a year to $30.6M, with an average return on invested capital of -20.2%.
- Graham intrinsic value
- $82.96
- Revenue (FY2024)
- $30.6M
- Revenue growth (6-yr CAGR)
- -17.2%
- ROIC (10-yr avg)
- -20.2%
- Free cash flow (FY2024)
- -$29.9M
PRE 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2024 | $30.6M | -$49.8M | -$3.71 | -$29.9M | -157.2% | — |
| FY2023 | $21.7M | -$64.8M | -$5.58 | -$14.1M | -238.7% | — |
| FY2022 | $275.8M | -$190.5M | -$2.50 | $9.6M | -8.5% | — |
| FY2021 | $275.9M | -$174.0M | -$2.38 | $4.9M | -3.7% | — |
| FY2020 | $65.2M | -$2.0M | -$0.03 | -$5.7M | -1.5% | — |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Prenetics Global Ltd revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Prenetics Global Ltd 10-year average ROIC is N/A; capital efficiency cannot be assessed from the available history.
Prenetics Global Ltd capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Prenetics Global Ltd is modeled at -17.2% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $82.96 per share.